Autres langues iCon Group Ltd

Actions

ICON

IL0011824849

Marché Fermé - TEL AVIV STOCK EXCHANGE Autres places de cotation 16:24:41 01/07/2024			Varia. 5j.	Varia. 1 janv.
382,9 ^ILa	+0,03%		-2,82%	-18,18%

27/05	ICon Group Ltd publie ses résultats pour le premier trimestre clos le 31 mars 2024	CI
28/03	ICon Group Ltd publie ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

ICon Group Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	27/05
ICon Group Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Radformation and Icon Group Unite to Transform Cancer Treatment and Workflows	14/02
Icon Group - Meet Our National Operations Manager for the UK, Claire Smith	12/02
Bowel Cancer Australia and Icon Cancer Centre announce new partnership to help close the care gap	08/02
Icon Singapore holds inaugural Regional Oncology Conference	30/01
Icon Singapore holds inaugural Radiation Oncology Conference	29/01
Icon - New radiation therapy service to give patients better access, more choice to cancer care	26/01
Icon Group and Nuffield Health announce next phase in strategic partnership for the delivery of oncology services in the UK	12/01
Icon Group celebrates a year of growth and pioneering advancements in healthcare	18/12
ICON secures upgraded credit rating from Moody's Investors Service	08/12
ICon Group Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29/11
Icon Group Appoints Russell Hill as Chief Operating Officer for Pharmacy	29/11
Russell Hill appointed to Icon's Chief Operating Officer for Pharmacy	29/11
Icon takes centre stage at London Global Cancer Week	22/11
Icon Group - Slade Pharmacy wins contract to provide pharmacy services for UnitingCare Queensland hospitals	19/10/23
Icon Sunsuria set to open its first cancer centre in Island Hospital	18/10/23
Icon launches theranostics, a personalised approach to cancer treatment	10/10/23
Icon Group leads global initiative to support cancer care in war-torn Ukraine	28/09/23
ICon Group Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	30/08/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues iCon Group Ltd

Actions

ICON

IL0011824849

Autres langues

Filtres